Some of the world's largest drugmakers will face an uphill battle next week in their bid to revive a class of experimental pain drugs that have been sidelined by safety concerns for nearly two years.
The Food and Drug Administration says there is a clear association between the nerve-blocking medications and reports of joint failure and bone deterioration that led the agency to halt studies of the drugs in 2010. However, the agency also notes that those side effects were less common when the drugs were used at lower doses, potentially leaving the door open for future use. The agency released its safety analysis ahead of a public meeting next week where outside experts will discuss the drugs' safety.
FOX NEWS
TONY DIGIROLAMO- FDA LINKS ONCE PROMISING PAIN DRUGS TO BONE DECAY?! GOTTA LOVE THAT HEADLINE.
Day after day as time goes by, Culture Shock keeps rising in the ... "You were right meter"!
No pain no gain ... the drug disaster in America.
There is a need for drugs and that science for sure ... However, after 3 heart attacks and 2 triple by-pass surgeries, I take meds. But not the Statins, to the dismay of my doctor. And I have whittled a couple of other meds out of my daily regimine with my doctors awareness and help to end them.
Just a reminder on the Statin story recently, FDA Cautions Statin Users on Side Effects:U.S. health regulators are adding warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to say they may raise levels of blood sugar and could cause memory loss.
The science and the business has run amok in the past couple of decades.
Often the side effects do out weigh the benefits. You may relieve the pain but the horror is far more painful.
No comments:
Post a Comment